sotalol has been researched along with Coronary Artery Disease in 6 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sotalol is a commonly prescribed antiarrhythmic drug (AAD) used for maintaining sinus rhythm in patients with atrial fibrillation (AF)." | 9.19 | Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease. ( Al-Khatib, SM; Allen-LaPointe, N; Anstrom, KJ; Daubert, JP; DeWald, T; Horton, JR; Lokhnygina, Y; Peterson, ED; Piccini, JP; Shaw, LK; Steinberg, BA; Thomas, K; Wojdyla, DM, 2014) |
| "The efficacy of oral sotalol in preventing sustained ventricular tachycardia induction by invasive electrophysiological testing was assessed in 22 patients (60 +/- 9 years) with prior myocardial infarction." | 7.68 | Efficacy and electrophysiologic effects of oral sotalol in patients with sustained ventricular tachycardia caused by coronary artery disease. ( Campa, MA; Dubuc, M; Kaltenbrunner, W; Kus, T; Nadeau, R; Shenasa, M, 1992) |
| "Sotalol is a commonly prescribed antiarrhythmic drug (AAD) used for maintaining sinus rhythm in patients with atrial fibrillation (AF)." | 5.19 | Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease. ( Al-Khatib, SM; Allen-LaPointe, N; Anstrom, KJ; Daubert, JP; DeWald, T; Horton, JR; Lokhnygina, Y; Peterson, ED; Piccini, JP; Shaw, LK; Steinberg, BA; Thomas, K; Wojdyla, DM, 2014) |
| "The efficacy of oral sotalol in preventing sustained ventricular tachycardia induction by invasive electrophysiological testing was assessed in 22 patients (60 +/- 9 years) with prior myocardial infarction." | 3.68 | Efficacy and electrophysiologic effects of oral sotalol in patients with sustained ventricular tachycardia caused by coronary artery disease. ( Campa, MA; Dubuc, M; Kaltenbrunner, W; Kus, T; Nadeau, R; Shenasa, M, 1992) |
| "As the population ages, recurrent ventricular tachycardia (VT) is increasingly encountered in elderly patients with ischemic heart disease." | 1.36 | Mortality and safety of catheter ablation for antiarrhythmic drug-refractory ventricular tachycardia in elderly patients with coronary artery disease. ( Inada, K; Koplan, BA; Roberts-Thomson, KC; Seiler, J; Steven, D; Stevenson, WG; Tedrow, UB, 2010) |
| "Amiodarone or sotalol was used in all postoperative patients for 6 months, except in 8 who had bradycardia." | 1.33 | Ablation of atrial fibrillation using microwave energy--early experience. ( Hamzeh, K; Jamil, H; Kabbani, SS; Murad, G; Sabbagh, A, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kiani, S | 1 |
| Sayegh, MN | 1 |
| Ibrahim, R | 1 |
| Bhatia, NK | 1 |
| Merchant, FM | 1 |
| Shah, AD | 1 |
| Westerman, SB | 1 |
| De Lurgio, DB | 1 |
| Patel, AM | 1 |
| Thompkins, CM | 1 |
| Leon, AR | 1 |
| Lloyd, MS | 1 |
| El-Chami, MF | 1 |
| Piccini, JP | 1 |
| Al-Khatib, SM | 1 |
| Wojdyla, DM | 1 |
| Shaw, LK | 1 |
| Horton, JR | 1 |
| Lokhnygina, Y | 1 |
| Anstrom, KJ | 1 |
| DeWald, T | 1 |
| Allen-LaPointe, N | 1 |
| Steinberg, BA | 1 |
| Thomas, K | 1 |
| Daubert, JP | 1 |
| Peterson, ED | 1 |
| Walsh, SN | 1 |
| Kerchner, K | 1 |
| Sangüeza, OP | 1 |
| Inada, K | 1 |
| Roberts-Thomson, KC | 1 |
| Seiler, J | 1 |
| Steven, D | 1 |
| Tedrow, UB | 1 |
| Koplan, BA | 1 |
| Stevenson, WG | 1 |
| Kabbani, SS | 1 |
| Murad, G | 1 |
| Jamil, H | 1 |
| Sabbagh, A | 1 |
| Hamzeh, K | 1 |
| Kus, T | 1 |
| Campa, MA | 1 |
| Nadeau, R | 1 |
| Dubuc, M | 1 |
| Kaltenbrunner, W | 1 |
| Shenasa, M | 1 |
1 trial available for sotalol and Coronary Artery Disease
| Article | Year |
|---|---|
Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cause of Death; Coronary Artery Disea | 2014 |
5 other studies available for sotalol and Coronary Artery Disease
| Article | Year |
|---|---|
The Feasibility and Safety of Flecainide Use Among Patients With Varying Degrees of Coronary Disease.
Topics: Coronary Artery Disease; Feasibility Studies; Flecainide; Humans; Retrospective Studies; Sotalol; Ta | 2023 |
Challenge. What is your diagnosis? Answer. Primary nodal diffuse large B-cell lymphoma with secondary cutaneous involvement.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Clopidogrel; C | 2009 |
Mortality and safety of catheter ablation for antiarrhythmic drug-refractory ventricular tachycardia in elderly patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Body Surface Pot | 2010 |
Ablation of atrial fibrillation using microwave energy--early experience.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Coronary Ar | 2005 |
Efficacy and electrophysiologic effects of oral sotalol in patients with sustained ventricular tachycardia caused by coronary artery disease.
Topics: Administration, Oral; Adult; Aged; Cardiac Pacing, Artificial; Coronary Artery Disease; Electrocardi | 1992 |